Cohance Lifesciences to attend Goldman Sachs, ISEC conferences

Cohance Lifesciences Limited (formerly, Suven Pharmaceuticals Limited) has informed stock exchanges that its management will attend the Goldman Sachs & ISEC Conferences in Singapore, Hong Kong, on September 18, 2025. This interaction is categorized as a "Group/One-one" meeting, indicating direct and focused discussions with analysts and institutional investors.

The company emphasized that no unpublished price-sensitive information will be shared. However, it noted that the meeting schedule is subject to change due to exigencies on the part of the analyst, institutional investor, or the company. The announcement was made to comply with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The announcement was signed by Kundan Kumar Jha, company secretary, compliance officer, and head-legal for Cohance Lifesciences Limited, and dated September 15, 2025.